Page 5 of 6
ACS Medicinal Chemistry Letters
new carbonic anhydrase VII inhibitors. Eur J Med Chem 2014, 71,
105-111.
Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic
anhydrase inhibitors: synthesis, biological evaluation, and enzyme--
ligand X-ray studies. J Med Chem 2010, 53 (6), 2401-2408.
1
2
3
4
5
6
7
8
(14) R. Gitto, S. Agnello, S. Ferro, D. Vullo, C. T. Supuran, A. Chimirri,
Identification of potent and selective human carbonic anhydrase VII
(hCA VII) inhibitors. ChemMedChem 2010, 5 (6), 823-826.
(15) M. F. Abo-Ashour, W. M. Eldehna, A. Nocentini, H. S. Ibrahim, S.
Bua, H. A. Abdel-Aziz, S. M. Abou-Seri, C. T. Supuran, Novel
synthesized SLC-0111 thiazole and thiadiazole analogues:
Determination of their carbonic anhydrase inhibitory activity and
molecular modeling studies. Bioorg Chem 2019, 87, 794-802.
(16) E. Andreucci, J. Ruzzolini, S. Peppicelli, F. Bianchini, A.
Laurenzana, F. Carta, C. T. Supuran, L. Calorini, The carbonic
anhydrase IX inhibitor SLC-0111 sensitises cancer cells to
conventional chemotherapy. J Enzyme Inhib Med Chem 2019, 34 (1),
117-123.
(17) N. H. Boyd, K. Walker, J. Fried, J. R. Hackney, P. C. McDonald, G.
A. Benavides, R. Spina, A. Audia, S. E. Scott, C. J. Libby, A. N.
Tran, M. O. Bevensee, C. Griguer, S. Nozell, G. Y. Gillespie, B.
Nabors, K. P. Bhat, E. E. Bar, V. Darley-Usmar, B. Xu, E. Gordon,
S. J. Cooper, S. Dedhar, A. B. Hjelmeland, Addition of carbonic
anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays
glioblastoma growth in vivo. JCI Insight 2017, 2 (24).
(28) R. Gitto, L. De Luca, S. Ferro, S. Agnello, E. Russo, G. De Sarro, A.
Chimirri, Synthesis and structure-active relationship of 1-aryl-6,7-
dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsants. Chem
Pharm Bull (Tokyo) 2010, 58 (12), 1602-1605.
(29) R. Gitto, F. M. Damiano, L. De Luca, S. Ferro, D. Vullo, C. T.
Supuran, A. Chimirri, Synthesis and biological profile of new
1,2,3,4-tetrahydroisoquinolines as selective carbonic anhydrase
inhibitors. Bioorg Med Chem 2011, 19 (23), 7003-7007.
(30) P. Mader, J. Brynda, R. Gitto, S. Agnello, P. Pachl, C. T. Supuran,
A. Chimirri, P. Rezacova, Structural basis for the interaction between
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
carbonic
anhydrase
and
1,2,3,4-tetrahydroisoquinolin-2-
ylsulfonamides. J Med Chem 2011, 54 (7), 2522-2526.
(31) R. Gitto, F. M. Damiano, P. Mader, L. De Luca, S. Ferro, C. T.
Supuran, D. Vullo, J. Brynda, P. Rezacova, A. Chimirri, Synthesis,
structure-activity relationship studies, and X-ray crystallographic
analysis of arylsulfonamides as potent carbonic anhydrase inhibitors.
J Med Chem 2012, 55 (8), 3891-3899.
(32) G. De Simone, V. Alterio, C. T. Supuran, Exploiting the hydrophobic
and hydrophilic binding sites for designing carbonic anhydrase
inhibitors. Expert Opin Drug Discov 2013, 8 (7), 793-810.
(33) M. R. Buemi, L. De Luca, S. Ferro, E. Bruno, M. Ceruso, C. T.
Supuran, K. Pospisilova, J. Brynda, P. Rezacova, R. Gitto, Carbonic
anhydrase inhibitors: Design, synthesis and structural
characterization of new heteroaryl-N-carbonylbenzenesulfonamides
targeting druggable human carbonic anhydrase isoforms. Eur J Med
Chem 2015, 102, 223-232.
(18) M. Bozdag, F. Carta, M. Ceruso, M. Ferraroni, P. C. McDonald, S.
Dedhar, C. T. Supuran, Discovery of 4-Hydroxy-3-(3-
(phenylureido)benzenesulfonamides as SLC-0111 Analogues for the
Treatment of Hypoxic Tumors Overexpressing Carbonic Anhydrase
IX. J Med Chem 2018, 61 (14), 6328-6338.
(19) F. Carta, D. Vullo, S. M. Osman, Z. AlOthman, C. T. Supuran,
Synthesis and carbonic anhydrase inhibition of a series of SLC-0111
analogs. Bioorg Med Chem 2017, 25 (9), 2569-2576.
(34) L. De Luca, F. Mancuso, S. Ferro, M. R. Buemi, A. Angeli, S. Del
Prete, C. Capasso, C. T. Supuran, R. Gitto, Inhibitory effects and
structural insights for a novel series of coumarin-based compounds
that selectively target human CA IX and CA XII carbonic
anhydrases. Eur J Med Chem 2018, 143, 276-282.
(20) W. M. Eldehna, M. F. Abo-Ashour, E. Berrino, D. Vullo, H. A.
Ghabbour, S. T. Al-Rashood, G. S. Hassan, H. M. Alkahtani, A. A.
Almehizia, A. Alharbi, H. A. Abdel-Aziz, C. T. Supuran, SLC-0111
enaminone
analogs,
3/4-(3-aryl-3-oxopropenyl)
aminobenzenesulfonamides, as novel selective subnanomolar
inhibitors of the tumor-associated carbonic anhydrase isoform IX.
Bioorg Chem 2019, 83, 549-558.
(35) R. Gitto, L. De Luca, F. Mancuso, S. Del Prete, D. Vullo, C. T.
Supuran, C. Capasso, Seeking new approach for therapeutic
treatment of cholera disease via inhibition of bacterial carbonic
anhydrases: experimental and theoretical studies for sixteen
benzenesulfonamide derivatives. J Enzyme Inhib Med Chem 2019,
34 (1), 1186-1192.
(36) C. L. Lomelino, J. T. Andring, R. McKenna, Crystallography and Its
Impact on Carbonic Anhydrase Research. Int J Med Chem 2018,
2018, 9419521.
(37) V. Alterio, A. Di Fiore, K. D'Ambrosio, C. T. Supuran, G. De
Simone, Multiple binding modes of inhibitors to carbonic
anhydrases: how to design specific drugs targeting 15 different
isoforms? Chem Rev 2012, 112 (8), 4421-4468.
(38) K. Hakansson, M. Carlsson, L. A. Svensson, A. Liljas, Structure of
native and apo carbonic anhydrase II and structure of some of its
anion-ligand complexes. J Mol Biol 1992, 227 (4), 1192-1204.
(39) N. Chiaramonte, S. Bua, M. Ferraroni, A. Nocentini, A. Bonardi, G.
Bartolucci, M. Durante, L. Lucarini, D. Chiapponi, S. Dei, D.
Manetti, E. Teodori, P. Gratteri, E. Masini, C. T. Supuran, M. N.
Romanelli, 2-Benzylpiperazine: A new scaffold for potent human
carbonic anhydrase inhibitors. Synthesis, enzyme inhibition,
enantioselectivity, computational and crystallographic studies and in
vivo activity for a new class of intraocular pressure lowering agents.
Eur J Med Chem 2018, 151, 363-375.
(40) V. Alterio, M. Hilvo, A. Di Fiore, C. T. Supuran, P. Pan, S. Parkkila,
A. Scaloni, J. Pastorek, S. Pastorekova, C. Pedone, A. Scozzafava,
S. M. Monti, G. De Simone, Crystal structure of the catalytic domain
of the tumor-associated human carbonic anhydrase IX. Proc Natl
Acad Sci U S A 2009, 106 (38), 16233-16238.
(21) W. M. Eldehna, M. F. Abo-Ashour, A. Nocentini, R. S. El-Haggar,
S. Bua, A. Bonardi, S. T. Al-Rashood, G. S. Hassan, P. Gratteri, H.
A. Abdel-Aziz, C. T. Supuran, Enhancement of the tail hydrophobic
interactions within the carbonic anhydrase IX active site via
structural extension: Design and synthesis of novel N-substituted
isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and
antitumor agents. Eur J Med Chem 2019, 162, 147-160.
(22) C. L. Lomelino, B. P. Mahon, R. McKenna, F. Carta, C. T. Supuran,
Kinetic and X-ray crystallographic investigations on carbonic
anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-
0111. Bioorg Med Chem 2016, 24 (5), 976-981.
(23) C. T. Supuran, V. Alterio, A. Di Fiore, D. A. K, F. Carta, S. M.
Monti, G. De Simone, Inhibition of carbonic anhydrase IX targets
primary tumors, metastases, and cancer stem cells: Three for the
price of one. Med Res Rev 2018, 38 (6), 1799-1836.
(24) E. Bruno, M. R. Buemi, A. Di Fiore, L. De Luca, S. Ferro, A. Angeli,
R. Cirilli, D. Sadutto, V. Alterio, S. M. Monti, C. T. Supuran, G. De
Simone, R. Gitto, Probing Molecular Interactions between Human
Carbonic Anhydrases (hCAs) and
a
Novel Class of
Benzenesulfonamides. J Med Chem 2017, 60 (10), 4316-4326.
(25) M. R. Buemi, A. Di Fiore, L. De Luca, A. Angeli, F. Mancuso, S.
Ferro, S. M. Monti, M. Buonanno, E. Russo, G. De Sarro, G. De
Simone, C. T. Supuran, R. Gitto, Exploring structural properties of
potent human carbonic anhydrase inhibitors bearing
a
4-
(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety. Eur
Med Chem 2019, 163, 443-452.
J
(26) R. Gitto, S. Ferro, S. Agnello, L. De Luca, G. De Sarro, E. Russo, D.
Vullo, C. T. Supuran, A. Chimirri, Synthesis and evaluation of
(41) R. A. Laskowski, M. B. Swindells, LigPlot+: multiple ligand-protein
interaction diagrams for drug discovery. J Chem Inf Model 2011, 51
(10), 2778-2786.
pharmacological
profile
of
1-aryl-6,7-dimethoxy-3,4-
dihydroisoquinoline-2(1H)-sulfonamides. Bioorg Med Chem 2009,
17 (10), 3659-3664.
(27) R. Gitto, S. Agnello, S. Ferro, L. De Luca, D. Vullo, J. Brynda, P.
Mader, C. T. Supuran, A. Chimirri, Identification of 3,4-
ACS Paragon Plus Environment